Results 21 to 30 of about 25,429 (227)

Carbapenem-resistant Acinetobacter baumannii outbreak at university hospital [PDF]

Brazilian Journal of Microbiology, 2009
Nineteen clonally related imipenem-resistant Acinetobacter baumannii isolates were recovered from eight intensive care unit patients. All isolates harboured bla OXA-51-like β-lactamase genes and showed the absence of 22 kDa fraction in outer membrane porin profile analysis.
Takagi, E.H., Lincopan, N., Cassettari, V.C., Passadore, L.F., Mamizuka, E.M., Martinez, M.B.   +5 more
openaire   +4 more sources

Colistin-Resistant Acinetobacter baumannii: Beyond Carbapenem Resistance [PDF]

Clinical Infectious Diseases, 2015
With an increase in the use of colistin methansulfonate (CMS) to treat carbapenem-resistant Acinetobacter baumannii infections, colistin resistance is emerging.Patients with infection or colonization due to colistin-resistant A. baumannii were identified at a hospital system in Pennsylvania. Clinical data were collected from electronic medical records.
Zubair A, Qureshi, Lauren E, Hittle, Jessica A, O'Hara, Jesabel I, Rivera, Alveena, Syed, Ryan K, Shields, Anthony W, Pasculle, Robert K, Ernst, Yohei, Doi   +8 more
openaire   +2 more sources

Activity of Imipenem, Meropenem, Cefepime, and Sulbactam in Combination with the β-Lactamase Inhibitor LN-1-255 against Acinetobacter spp.

Antibiotics, 2021
Treatment of infections caused by Acinetobacter spp., particularly A. baumannii, is a major clinical problem due to its high rates of antibiotic resistance.
Cristina Lasarte-Monterrubio, Juan C. Vázquez-Ucha, Maria Maneiro, Jorge Arca-Suárez, Isaac Alonso, Paula Guijarro-Sánchez, John D. Buynak, Germán Bou, Concepción González-Bello, Alejandro Beceiro   +9 more
doaj   +1 more source

Antimicrobial Activity of a Repurposed Harmine-Derived Compound on Carbapenem-Resistant Acinetobacter baumannii Clinical Isolates

Frontiers in Cellular and Infection Microbiology, 2022
ObjectivesThe spread of antibiotic resistant bacteria is an important threat for human health. Acinetobacter baumannii bacteria impose such a major issue, as multidrug- to pandrug-resistant strains have been isolated, rendering some infections ...
Anke Breine, Anke Breine, Mégane Van Gysel, Mathias Elsocht, Clémence Whiteway, Clémence Whiteway, Chantal Philippe, Théo Quinet, Théo Quinet, Adam Valcek, Adam Valcek, Johan Wouters, Steven Ballet, Charles Van der Henst, Charles Van der Henst   +14 more
doaj   +1 more source

Carbapenem-resistant Acinetobacter baumannii: in pursuit of an effective treatment [PDF]

Clinical Microbiology and Infection, 2019
Carbapenem-resistant Acinetobacter baumannii (CRAB) has gained global notoriety as a critically important nosocomial pathogen. It mostly affects debilitated patients, causing pneumonia and bloodstream infections with high mortality rates. Difficulties in treating CRAB infections stem from a formidable resistance profile that leaves available only a few
Piperaki, E.-T., Tzouvelekis, L.S., Miriagou, V., Daikos, G.L.   +3 more
openaire   +3 more sources

Early dissemination of OXA-72-producing Acinetobacter baumannii strain in Colombia: a case report

Brazilian Journal of Infectious Diseases, 2014
Nosocomial infections caused by carbapenem-resistant Acinetobacter baumannii isolates have reached epidemic levels in past decades. Currently this microorganism is responsible for outbreaks of difficult eradication and with high mortality rates worldwide.
Sandra Yamile Saavedra, Rodrigo Cayô, Ana Cristina Gales, Aura Lucia Leal, Carlos Humberto Saavedra   +4 more
doaj   +1 more source

Polyvinylpyrrolidone-Capped Silver Nanoparticle Inhibits Infection of Carbapenem-Resistant Strain of Acinetobacter baumannii in the Human Pulmonary Epithelial Cell

Frontiers in Immunology, 2017
Acinetobacter baumannii, an opportunistic ESKAPE pathogen, causes respiratory and urinary tract infections. Its prevalence increases gradually in the clinical setup.
Vishvanath Tiwari, Monalisa Tiwari, Vandana Solanki   +2 more
doaj   +1 more source

Carbapenem resistance in Acinetobacter baumannii: the molecular epidemic features of an emerging problem in health care facilities

Journal of Infection in Developing Countries, 2009
Acinetobacter baumannii is an opportunistic gram-negative pathogen with increasing relevance in a variety of nosocomial infections especially among intensive-care-unit (ICU) patients. Carbapenems have been widely used to treat serious multidrug-resistant
Raffaele Zarrilli, Maria Giannouli, Federica Tomasone, Maria Triassi, Athanassios Tsakris   +4 more
doaj   +1 more source

Carbapenem Resistance in Acinetobacter nosocomialis and Acinetobacter junii Conferred by Acquisition of blaOXA-24/40 and Genetic Characterization of the Transmission Mechanism between Acinetobacter Genomic Species

Microbiology Spectrum, 2022
Carbapenem resistance is increasing among Gram-negative bacteria, including the genus Acinetobacter. This study aimed to characterize, for the first time, the development of carbapenem resistance in clinical isolates of Acinetobacter junii and ...
Cristina Lasarte-Monterrubio, Paula Guijarro-Sánchez, Alba Bellés, Juan Carlos Vázquez-Ucha, Jorge Arca-Suárez, Carlos Fernández-Lozano, German Bou, Alejandro Beceiro   +7 more
doaj   +1 more source

Acinetobacter baumannii and Its Relationship to Carbapenem Resistance: A Meta-Analysis

Bacteria, 2022
Infections by antibiotic-resistant bacteria are a significant and complex global health issue. In this context, Acinetobacter baumannii is particularly important because of its ability to withstand treatments by β-lactams, such as carbapenem. The objective of this work was to investigate, through systematic analysis and meta-analysis, the chance of ...
Diego Lucas Neres Rodrigues, Francielly Morais Rodrigues da Costa, Wanderson Marques da Silva, Flavia Aburjaile, Vasco Azevedo   +4 more
openaire   +3 more sources